Evolent Health Files 8-K for Material Agreement

Ticker: EVH · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1628908

Evolent Health, INC. 8-K Filing Summary
FieldDetail
CompanyEvolent Health, INC. (EVH)
Form Type8-K
Filed DateJun 20, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, 8-K, disclosure

Related Tickers: EVH

TL;DR

EVH signed a big deal, filing 8-K today.

AI Summary

Evolent Health, Inc. filed an 8-K on June 19, 2025, reporting the entry into a material definitive agreement. The filing also includes Regulation FD disclosures and other events, along with financial statements and exhibits. The company is incorporated in Delaware and headquartered in Arlington, Virginia.

Why It Matters

This filing indicates a significant new contract or partnership for Evolent Health, which could impact its future revenue and strategic direction.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's financial performance and stock price.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Evolent Health, Inc.?

The filing states the entry into a material definitive agreement but does not provide specific details about the agreement's nature in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 19, 2025.

Where are Evolent Health, Inc.'s principal executive offices located?

Evolent Health, Inc.'s principal executive offices are located at 1812 N. Moore Street, Suite 1705, Arlington, Virginia.

What is Evolent Health, Inc.'s state of incorporation?

Evolent Health, Inc. is incorporated in Delaware.

What is the Commission File Number for Evolent Health, Inc.?

The Commission File Number for Evolent Health, Inc. is 001-37415.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Evolent Health, Inc. (EVH).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing